GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurologix Inc (GREY:NRGXQ) » Definitions » LT-Debt-to-Total-Asset

Neurologix (Neurologix) LT-Debt-to-Total-Asset : 0.00 (As of Jun. 2011)


View and export this data going back to . Start your Free Trial

What is Neurologix LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Neurologix's long-term debt to total assests ratio for the quarter that ended in Jun. 2011 was 0.00.

Neurologix's long-term debt to total assets ratio stayed the same from Jun. 2010 (0.00) to Jun. 2011 (0.00).


Neurologix LT-Debt-to-Total-Asset Historical Data

The historical data trend for Neurologix's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurologix LT-Debt-to-Total-Asset Chart

Neurologix Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Neurologix Quarterly Data
Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Neurologix LT-Debt-to-Total-Asset Calculation

Neurologix's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2010 is calculated as

LT Debt to Total Assets (A: Dec. 2010 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2010 )/Total Assets (A: Dec. 2010 )
=0/9.677
=

Neurologix's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2011 is calculated as

LT Debt to Total Assets (Q: Jun. 2011 )=Long-Term Debt & Capital Lease Obligation (Q: Jun. 2011 )/Total Assets (Q: Jun. 2011 )
=0/4.963
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurologix  (GREY:NRGXQ) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Neurologix LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Neurologix's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurologix (Neurologix) Business Description

Traded in Other Exchanges
N/A
Address
One Bridge Plaza, Fort Lee, NJ, USA, 07024
Neurologix Inc is a development stage company that is engaged in the research and development of proprietary treatments for disorders of the brain and central nervous system, using gene transfer and other innovative therapies.

Neurologix (Neurologix) Headlines

No Headlines